Skip to main content
NVDA-0.53%AAPL-0.82%GOOGL+0.74%MSFT-0.84%AMZN-0.31%TSM+0.32%SPCX-3.23%AVGO+1.81%TSLA-1.28%META-1.70%LLY+0.46%BRK-B0.00%SKHY+12.62%MU+4.14%WMT-0.19%AMD+1.84%JPM+0.97%V+0.08%XOM+1.66%JNJ+1.08%ASMLa+1.33%MA+0.49%ABBV+0.44%INTC+0.58%1398.HK+0.13%CVX+1.27%0700.HK+0.62%COST-0.69%CSCO-1.22%KO+0.56%ORCL+5.40%UNH-0.50%PG-0.26%BAC+0.33%1816.HK-1.08%3988.HK-0.33%CAT+0.28%AMAT+4.89%AP2d+4.38%PM+0.31%HD-0.19%LRCX+5.12%DELL-1.58%0857.HK-1.09%GE+1.46%0939.HK-0.80%1288.HK+0.30%NVS-0.67%0005.HK+0.97%MS+1.36%NZDUSD-1.51%AUDNZD+1.50%NZDCAD-1.25%NZDMXN-1.13%NZDSGD-1.03%GBPNZD+0.93%USDJPY+0.93%AUDJPY+0.91%NZDCHF-0.90%EURNZD+0.86%NOKJPY+0.83%CHFNOK-0.73%CADJPY+0.66%EURUSD-0.65%USDCHF+0.65%AUDCHF+0.65%EURAUD-0.63%NZDJPY-0.62%USDNOK-0.60%GBPUSD-0.60%GBPAUD-0.58%EURNOK-0.55%AUDNOK-0.47%GBPTRY+0.41%CADCHF+0.37%EURCAD-0.36%EURZAR+0.36%GBPCAD-0.33%GBPJPY+0.32%GBPHKD+0.32%USDZAR+0.31%CHFSEK-0.29%CHFJPY+0.29%AUDSGD+0.29%EURJPY+0.29%GBPMXN-0.28%USDCAD+0.28%USDTRY+0.27%AUDCAD+0.26%GBPZAR+0.22%EURSGD+0.22%EURCZK+0.18%USDSEK-0.17%EURPLN+0.17%USDILS+0.16%USDSGD+0.16%USDPLN+0.12%EURSEK-0.12%PLNJPY+0.11%GBPSGD+0.08%AUDDKK+0.06%EURHKD+0.06%SGDJPY+0.06%USDDKK-0.06%USDTHB+0.05%USDMXN+0.05%EURCNH+0.05%EURGBP-0.05%USDHKD+0.05%GBPCHF+0.04%USDCOP-0.04%USDCNH-0.04%CHFSGD+0.03%AUDUSD-0.02%EURCHF-0.02%EURDKK-0.01%USOIL+2.71%UKOIL+1.74%XAGUSD-1.69%GAGUSD-1.69%XPTUSD-0.71%XAUUSD-0.67%GAUUSD-0.67%HG1-0.14%XNGUSD+0.03%COFFEE0.00%COCOA0.00%COTTON0.00%BTCUSD-0.01%ETHUSD+22.55%USDTUSD0.00%XRPUSD+12.79%SOLUSD+16.94%TRXUSDT-0.36%ZECUSDT-1.90%DOGEUSD+18.62%XMRUSDT-1.12%LINKUSD+23.58%BCHUSDT-4.88%XLMUSD-0.11%UNIUSD+0.34%LTCUSD+16.21%SUIUSD-0.76%HBARUSDT-1.80%TONUSD+39.55%TAOUSDT-0.89%AAVEUSD-0.91%DOTUSDT-0.40%ICPUSDT-0.28%ONDOUSDT-1.38%WLDUSDT-3.31%ARBUSDT+0.23%JUPUSDT-0.75%ATOMUSDT-0.81%INJUSDT-2.32%STXUSDT-1.71%TIAUSDT-1.73%FETUSDT-0.98%PYTHUSDT-2.53%SEIUSDT-0.79%IMXUSDT-1.78%GRTUSDT-1.06%OPUSDT-1.19%WIFUSDT+0.28%IOTAUSDT-3.51%POLUSDT-1.36%AXSUSDT-1.44%EOSUSDT-0.10%FARTCOINUSDT-1.62%DYDXUSDT+0.18%GALAUSDT-0.96%ORDIUSDT-1.98%RONINUSDT-2.72%NOTUSDT+0.18%NVDA-0.53%AAPL-0.82%GOOGL+0.74%MSFT-0.84%AMZN-0.31%TSM+0.32%SPCX-3.23%AVGO+1.81%TSLA-1.28%META-1.70%LLY+0.46%BRK-B0.00%SKHY+12.62%MU+4.14%WMT-0.19%AMD+1.84%JPM+0.97%V+0.08%XOM+1.66%JNJ+1.08%ASMLa+1.33%MA+0.49%ABBV+0.44%INTC+0.58%1398.HK+0.13%CVX+1.27%0700.HK+0.62%COST-0.69%CSCO-1.22%KO+0.56%ORCL+5.40%UNH-0.50%PG-0.26%BAC+0.33%1816.HK-1.08%3988.HK-0.33%CAT+0.28%AMAT+4.89%AP2d+4.38%PM+0.31%HD-0.19%LRCX+5.12%DELL-1.58%0857.HK-1.09%GE+1.46%0939.HK-0.80%1288.HK+0.30%NVS-0.67%0005.HK+0.97%MS+1.36%NZDUSD-1.51%AUDNZD+1.50%NZDCAD-1.25%NZDMXN-1.13%NZDSGD-1.03%GBPNZD+0.93%USDJPY+0.93%AUDJPY+0.91%NZDCHF-0.90%EURNZD+0.86%NOKJPY+0.83%CHFNOK-0.73%CADJPY+0.66%EURUSD-0.65%USDCHF+0.65%AUDCHF+0.65%EURAUD-0.63%NZDJPY-0.62%USDNOK-0.60%GBPUSD-0.60%GBPAUD-0.58%EURNOK-0.55%AUDNOK-0.47%GBPTRY+0.41%CADCHF+0.37%EURCAD-0.36%EURZAR+0.36%GBPCAD-0.33%GBPJPY+0.32%GBPHKD+0.32%USDZAR+0.31%CHFSEK-0.29%CHFJPY+0.29%AUDSGD+0.29%EURJPY+0.29%GBPMXN-0.28%USDCAD+0.28%USDTRY+0.27%AUDCAD+0.26%GBPZAR+0.22%EURSGD+0.22%EURCZK+0.18%USDSEK-0.17%EURPLN+0.17%USDILS+0.16%USDSGD+0.16%USDPLN+0.12%EURSEK-0.12%PLNJPY+0.11%GBPSGD+0.08%AUDDKK+0.06%EURHKD+0.06%SGDJPY+0.06%USDDKK-0.06%USDTHB+0.05%USDMXN+0.05%EURCNH+0.05%EURGBP-0.05%USDHKD+0.05%GBPCHF+0.04%USDCOP-0.04%USDCNH-0.04%CHFSGD+0.03%AUDUSD-0.02%EURCHF-0.02%EURDKK-0.01%USOIL+2.71%UKOIL+1.74%XAGUSD-1.69%GAGUSD-1.69%XPTUSD-0.71%XAUUSD-0.67%GAUUSD-0.67%HG1-0.14%XNGUSD+0.03%COFFEE0.00%COCOA0.00%COTTON0.00%BTCUSD-0.01%ETHUSD+22.55%USDTUSD0.00%XRPUSD+12.79%SOLUSD+16.94%TRXUSDT-0.36%ZECUSDT-1.90%DOGEUSD+18.62%XMRUSDT-1.12%LINKUSD+23.58%BCHUSDT-4.88%XLMUSD-0.11%UNIUSD+0.34%LTCUSD+16.21%SUIUSD-0.76%HBARUSDT-1.80%TONUSD+39.55%TAOUSDT-0.89%AAVEUSD-0.91%DOTUSDT-0.40%ICPUSDT-0.28%ONDOUSDT-1.38%WLDUSDT-3.31%ARBUSDT+0.23%JUPUSDT-0.75%ATOMUSDT-0.81%INJUSDT-2.32%STXUSDT-1.71%TIAUSDT-1.73%FETUSDT-0.98%PYTHUSDT-2.53%SEIUSDT-0.79%IMXUSDT-1.78%GRTUSDT-1.06%OPUSDT-1.19%WIFUSDT+0.28%IOTAUSDT-3.51%POLUSDT-1.36%AXSUSDT-1.44%EOSUSDT-0.10%FARTCOINUSDT-1.62%DYDXUSDT+0.18%GALAUSDT-0.96%ORDIUSDT-1.98%RONINUSDT-2.72%NOTUSDT+0.18%
DT

Definium Therapeutics, Inc. (DFTX)

NASDAQ • Healthcare

$37.08
+$1.39 (+3.9%)
Market open

Last close at October 27, 2026 at 20:00 UTC

Open$35.42
Previous Close$37.08
Day Range$35.18 - $37.61
Avg. Volume (3M)1.9M
Market Cap$5.1B
52 Week Range
$10.46$49.7
Next EarningsIn 8 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$353.7M
EPS (TTM)
-$3.44
ROA (TTM)
-31.79%
Current Ratio
6.95

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-5.4%Q1 2026-$0.51
-51.1%Q2 2026-$0.71
-166.2%Q3 2026-$1.44
Next

Nov 5

in 8 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -166.2%

Definium Therapeutics’ adjusted EPS missed expectations as preliminary results for the second fiscal quarter of 2026, reported August 6, 2026, showed EPS of $-1.44 trailed the $-0.54 estimate, -166%. GAAP net loss widened to roughly $159.0 million, down -271.9% year over year from about $42.7 million, alongside operating income of about -$75.1 million as the company remained in a loss position for the quarter. On a per-share basis, EPS was down -188.0% year over year versus $-0.50 a year ago. Cash flow also reflected the loss-making profile, with negative operating cash flow of roughly $52.8 million. Consensus for the next period calls for EPS of $-0.54.

Next report — what to expect

Definium Therapeutics, Inc. (DFTX) reports next on November 5, 2026. Wall Street is looking for consensus EPS of -$0.561. Historically, results have been mixed, with the company beating EPS in 2 of 8 most recent quarters; traders will be focused on the EPS print versus that benchmark.

View full earnings history

About Definium Therapeutics, Inc.

Definium Therapeutics, Inc. is a NASDAQ-listed Healthcare company in Biotechnology that operates as a clinical-stage biopharmaceutical firm focused on brain health and neurological disorders. The company develops drug candidates for central nervous system conditions and, in qualitative terms, fits the profile of an early-stage biotech rather than a commercialized drug maker.

Name
Definium Therapeutics, Inc.
CEO
Robert Barrow
Website
definiumtx.com
Industry
Healthcare
Employees
106

Today's Snapshot

AI-generated

DFTX is trading 2.2% above yesterday's close, while its sector was flat. Earnings are due from DFTX on 5 November.

Trading Volume

Below 10d avg (1.7M)

687.8K

vs S&P 500 Today

Outperforming Market

+2.04%

Updated: October 28, 2026 at 16:43 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
DFTX presents a constructive short-term setup, with the share price above several short- and medium-term averages and comfortably above the 200-day level, while on-balance volume supports accumulation. Momentum indicators are positive and the CCI shows strength, even as the ADX points to a relatively weak directional trend and the MACD remains near neutral. Volatility is moderate by ATR and the pivot lies below the current price, providing a reference level for intraday action. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$28.90 - $37.22
    Buy
  • RSI (14)56.97
    Neutral
  • Stochastic %K (14, 3, 3)79.59
    Neutral
  • MACD Level (12, 26)-0.41
    Neutral

Peers & Related Assets

PRAXPraxis Precision Medicines, Inc.
$267.59+0.1%
AXSMAxsome Therapeutics, Inc.
$142.2-1.3%
RAPPRapport Therapeutics, Inc. Common Stock
$27.54+8.7%
MPLTMapLight Therapeutics, Inc.
$8.17+6.7%
GHRSGH Research PLC
LBRXLB Pharmaceuticals Inc Common Stock
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.